Sign in Subscribe
Drugs

Biotechnology Companies to Showcase at Techvest LLC's 2nd Annual Tissue Repair, Replacement and Regeneration Conference

Strategic Insights

— 1 min read

More than 50 leading biotechnology companies, both public and private, will converge at Techvest LLC's 2nd Annual Tissue Repair, Replacement and Regeneration Conference to network with institutional investors, venture capitalists, and industry professionals. InformedInvestors.com will webcast the event, providing access to the conference for those unable to attend onsite. Advanced Tissue Sciences, Ariad Pharmaceuticals, and Tutogen Medical, among other companies, will participate in the conference, highlighting their innovative technologies and products in the field of tissue repair and regeneration.

Key Takeaways:

  • Over 50 biotechnology companies, including public and private entities, will participate in the conference.
  • Companies will network with institutional investors, venture capitalists, accredited investors, industry executives, and academic and medical professionals.
  • Advanced Tissue Sciences will showcase its proprietary core technology for tissue repair and transplantation.
  • Ariad Pharmaceuticals will highlight its proprietary platform technologies and small-molecule therapeutic products based on gene regulation and signal transduction.
  • Tutogen Medical will feature its tissue processing and worldwide distribution of specialty surgical products for various surgical applications.
  • Companies participating in the conference include Aastrom Biosciences, Encelle, Advanced Materials Design, LLC, and many others.

Statistics:

  • More than 50 biotechnology companies will participate in the conference.
  • The conference will provide access to institutional investors, venture capitalists, and industry professionals.
  • Advanced Tissue Sciences has two joint ventures and a strategic alliance developing products to treat various tissue-related ailments.
  • Ariad Pharmaceuticals has developed proprietary platform technologies and small-molecule therapeutic products.
  • Tutogen Medical has consolidated subsidiaries engaged in tissue processing and worldwide distribution of specialty surgical products.

Sources:

  • InformedInvestors.com
  • PRNewswire (Nov. 7)
  • Techvest LLC
  • Advanced Tissue Sciences (Nasdaq: ATIS)
  • Ariad Pharmaceuticals, Inc. (Nasdaq: ARIA)
  • Tutogen Medical, Inc. (Amex: TTG)

Read more